Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Hobday

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Progress in Cardiovascular Diseases|May 15, 2007
Carcinoid heart diseaseAlain M Bernheim, Heidi M Connolly, Timothy J Hobday, et al.
Oncotargets and Therapy|May 21, 2020
Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent InsightsJason S Starr, Mohamad Bassam Sonbol, Timothy J Hobday, et al.
Neuroendocrinology|May 24, 2019
The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine NeoplasmsHao Xie, Junjia Liu, Siddhartha Yadav, et al.
Pancreas|January 18, 2022
Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine TumorsMojun Zhu, Brian A Costello, Jun Yin, et al.
JCO Precision Oncology|February 11, 2020
Dose modification for safe treatment of a compound complex heterozygous <i>DPYD</i> variant carrier with 5-fluorouracilShikshya Shrestha, Erin E Tapper, Colbren Scout Trogstad-Isaacson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomasBettina Papouchado, Lori A Erickson, Audrey L Rohlinger, et al.
Pancreas|April 14, 2020
Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine CarcinomaPatrick W McGarrah, Konstantinos Leventakos, Timothy J Hobday, et al.
Pancreas|October 8, 2014
Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control studyThorvardur R Halfdanarson, William R Bamlet, Robert R McWilliams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 20, 2021
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide TherapyChristopher E Wee, Ayca Dundar, Rachel A Eiring, et al.
Clinical Genitourinary Cancer|January 9, 2020
Renal Neuroendocrine Neoplasms: A Single-center ExperiencePatrick W McGarrah, Gustavo F M Westin, Timothy J Hobday, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Progress in Cardiovascular Diseases|May 15, 2007
Carcinoid heart diseaseAlain M Bernheim, Heidi M Connolly, Timothy J Hobday, et al.
Oncotargets and Therapy|May 21, 2020
Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent InsightsJason S Starr, Mohamad Bassam Sonbol, Timothy J Hobday, et al.
Neuroendocrinology|May 24, 2019
The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine NeoplasmsHao Xie, Junjia Liu, Siddhartha Yadav, et al.
Pancreas|January 18, 2022
Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine TumorsMojun Zhu, Brian A Costello, Jun Yin, et al.
JCO Precision Oncology|February 11, 2020
Dose modification for safe treatment of a compound complex heterozygous <i>DPYD</i> variant carrier with 5-fluorouracilShikshya Shrestha, Erin E Tapper, Colbren Scout Trogstad-Isaacson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomasBettina Papouchado, Lori A Erickson, Audrey L Rohlinger, et al.
Pancreas|April 14, 2020
Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine CarcinomaPatrick W McGarrah, Konstantinos Leventakos, Timothy J Hobday, et al.
Pancreas|October 8, 2014
Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control studyThorvardur R Halfdanarson, William R Bamlet, Robert R McWilliams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 20, 2021
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide TherapyChristopher E Wee, Ayca Dundar, Rachel A Eiring, et al.
Clinical Genitourinary Cancer|January 9, 2020
Renal Neuroendocrine Neoplasms: A Single-center ExperiencePatrick W McGarrah, Gustavo F M Westin, Timothy J Hobday, et al.
Pageof 8